Savient Pharmaceuticals Inc (SVNT) CEO John Johnson buys 11,000 Shares

CEO & President of Savient Pharmaceuticals Inc (SVNT, Financial) John Johnson buys 11,000 shares of SVNT on 11/18/2011 at an average price of $2.29 a share.

Savient Pharmaceuticals Inc. has a market cap of $167.79 million; its shares were traded at around $2.35 with and P/S ratio of 41.65. Savient Pharmaceuticals Inc. had an annual average earning growth of 79.7% over the past 5 years.

CEO Recent Trades:

  • CEO & President John Johnson bought 28,000 shares of SVNT stock on 09/16/2011 at the average price of 4.09. John Johnson owns at least 258,000 shares after this. The price of the stock has decreased by 42.54% since.

CFO Recent Trades:

  • EVP, CFO Kenneth J Zuerblis bought 5,000 shares of SVNT stock on 09/15/2011 at the average price of 4.03. Kenneth J Zuerblis owns at least 5,000 shares after this. The price of the stock has decreased by 41.69% since.

Directors and Officers Recent Trades:

  • SVP, Chief Medical Officer Kenneth Bahrt bought 5,000 shares of SVNT stock on 11/16/2011 at the average price of 2.59. Kenneth Bahrt owns at least 58,000 shares after this. The price of the stock has decreased by 9.27% since.
  • SVP, General Counsel Philip K Yachmetz bought 7,000 shares of SVNT stock on 09/16/2011 at the average price of 4.13. Philip K Yachmetz owns at least 189,024 shares after this. The price of the stock has decreased by 43.1% since.
  • Director Alan L Heller bought 7,500 shares of SVNT stock on 09/15/2011 at the average price of 3.99. Alan L Heller owns at least 40,179 shares after this. The price of the stock has decreased by 41.1% since.
  • SVP, Chief Medical Officer Kenneth Bahrt bought 3,000 shares of SVNT stock on 09/14/2011 at the average price of 3.95. Kenneth Bahrt owns at least 105,500 shares after this. The price of the stock has decreased by 40.51% since.


For the complete insider trading history of SVNT, click here.